National Asset Management, Inc. Sorrento Therapeutics, Inc. Transaction History

National Asset Management, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$1.51 - $2.88 $18,414 - $35,121	12,195 New	12,195 $20,000
Q4 2021 Jan 28, 2022	SELL	$4.65 - $7.23 $80,910 - $125,802	-17,400 Closed	0 $0
Q3 2021 Nov 16, 2021	SELL	$7.41 - $10.99 $29,032 - $43,058	-3,918 Reduced 18.38%	17,400 $133,000
Q2 2021 Aug 10, 2021	SELL	$6.35 - $10.0 $93,662 - $147,500	-14,750 Reduced 40.89%	21,318 $207,000
Q1 2021 May 13, 2021	SELL	$7.03 - $16.51 $29,793 - $69,969	-4,238 Reduced 10.51%	36,068 $299,000
Q4 2020 Feb 04, 2021	BUY	$5.76 - $11.95 $74,413 - $154,382	12,919 Added 47.17%	40,306 $276,000
Q3 2020 Nov 09, 2020	SELL	$6.17 - $18.82 $46,515 - $141,883	-7,539 Reduced 21.59%	27,387 $304,000
Q2 2020 Jul 31, 2020	BUY	$1.73 - $6.76 $60,421 - $236,099	34,926 New	34,926 $220,000

5.47M

Ticker SRNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 449,952,000
Market Cap $148M
Description
Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...

Get notified when there are updates to the investment portfolio of National Asset Management, Inc., based on Form 13F filings with the SEC.

Stay updated on National Asset Management, Inc. with notifications on news.